Clinical Trial Update: Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and biological activity of the InfraDure Biopump delivering sustained interferon in patients with Hepatitis C; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• InfraDure Biopump Secreting Sustained Interferon (interferon)

Snippet

Sponsor: Medgenics Medical Israel Ltd. | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: TERMINATED